So we turned to an expert on the subject to address the top five concerns women have about starting GLP-1 meds like Ozempic. Here, how to outsmart common side effects and hurdles.  Meet our Ozempic ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least 3 years in adults with overweight or ...

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

HealthDay News — Among US adults without diabetes, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) increased from 2018 to 2022, reaching annual prevalence of 0.4% in 2022, according ...

However, even with its relatively lower price compared to the US, the question remains — can she truly afford it? And if she ...